{
  "ticker": "ESPR",
  "company_name": "Esperion Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02044627",
      "title": "Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Hyperlipidemia",
      "start_date": "2013-12",
      "completion_date": "2014-01",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT01262638",
      "title": "A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Dyslipidemia",
      "start_date": "2010-12",
      "completion_date": "2011-08-23",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06021951",
      "title": "Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Healthy Lactating Women",
      "start_date": "2023-08-04",
      "completion_date": "2024-03-22",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT01751984",
      "title": "A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypercholesterolemia",
      "start_date": "2012-10-04",
      "completion_date": "2013-05-01",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05103254",
      "title": "Bempedoic Acid Pregnancy Surveillance Program",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Pregnancy, Hyperlipidemias",
      "start_date": "2021-09-01",
      "completion_date": "2032-05",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03001076",
      "title": "Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypercholesterolemia, Atherosclerosis, Statin Adverse Reaction",
      "start_date": "2016-11-29",
      "completion_date": "2018-02-12",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03337308",
      "title": "A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hyperlipidemias",
      "start_date": "2017-10-23",
      "completion_date": "2018-07-18",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03531905",
      "title": "Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes, Diabetes Mellitus, Type 2, Cholesterolemia",
      "start_date": "2018-05-09",
      "completion_date": "2019-06-18",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03067441",
      "title": "Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypercholesterolemia, Atherosclerotic Cardiovascular Disease",
      "start_date": "2017-02-03",
      "completion_date": "2019-11-05",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    },
    {
      "nct_id": "NCT02178098",
      "title": "Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypercholesterolemia, Hypertension",
      "start_date": "2014-06-16",
      "completion_date": "2015-05-22",
      "enrollment": 0,
      "sponsor": "Esperion Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 26,
    "by_phase": {
      "PHASE1": 3,
      "PHASE2": 12,
      "PHASE4": 2,
      "": 1,
      "PHASE3": 7,
      "NA": 1
    },
    "by_status": {
      "COMPLETED": 23,
      "RECRUITING": 2,
      "UNKNOWN": 1
    },
    "active_trials": 2,
    "completed_trials": 23,
    "conditions": [
      "Cardiovascular Diseases, NSTEMI, STEMI",
      "Cardiovascular Diseases, Statin Adverse Reaction",
      "Diabetes, Diabetes Mellitus, Type 2, Cholesterolemia",
      "Dyslipidemia",
      "Healthy Lactating Women",
      "Hypercholesterolemia",
      "Hypercholesterolemia, Atherosclerosis, Statin Adverse Reaction",
      "Hypercholesterolemia, Atherosclerotic Cardiovascular Disease",
      "Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Statin Adverse Reaction",
      "Hypercholesterolemia, Atherosclerotic Cardiovascular Diseases",
      "Hypercholesterolemia, Hypertension",
      "Hyperlipidemia",
      "Hyperlipidemia, Type 2 Diabetes",
      "Hyperlipidemias",
      "Mild Dyslipidemia",
      "Peripheral Artery Disease, Peripheral Vascular Diseases, Dyslipidemias",
      "Pregnancy, Hyperlipidemias",
      "Safety Evaluation of Escalating Doses"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:15.438493",
    "search_query": "Esperion Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Esperion+Therapeutics,+Inc."
  }
}